Concord Biotech
Finance
Quadria Capital set to finish returning first fund, eyes new vehicle's first close
Quadria Capital, a healthcare-focused investor, has started distributing the gains from its 10-year -old first fund, along with the principal, ......
Healthcare
Concord Biotech gains 27% on stock market debut as valuation tops $1 bn
Concord Biotech, a pharmaceutical ingredients maker, made a strong stock market debut on Friday with its shares listing at a ......
Healthcare
Quadria set to score another modest exit from India portfolio
Quadria Capital, a healthcare-focused private equity firm that recently committed around $158 million to GSK Velu-led eyecare chain Maxivision Eye Hospital, is looking at ......
General
Grapevine: Warburg eyes Brookfield's IT services bet; Concord, Manappuram arm gear up for IPOs
Private equity firm Warburg Pincus is in advanced talks to acquire an IT services business owned by Brookfield Asset Management, ......
Healthcare
Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO
Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital ......
Healthcare
Quadria Capital to sell stake in API maker Concord Biotech
Healthcare-focused private equity fund Quadria Capital will sell its entire 20% stake in active pharmaceutical ingredients maker Concord Biotech in ......
Healthcare
Quadria Capital-backed Concord Biotech Pvt pivots to IPO, appoints banker
Quadria Capital-backed Concord Biotech has appointed a merchant bank as it moves a step forward towards raising capital via a ......
Healthcare
Quadria Capital preparing to exit biotech firm
India and Southeast Asia-focused Quadria Capital is preparing to exit a biotech portfolio firm as deals in the broader pharmaceuticals ......
Healthcare
Quadria Capital hits the road for new healthcare PE fund
Quadria Capital, a private equity firm which focuses on South- and Southeast Asia, has hit the road to raise its ......
Healthcare
Kedaara Capital scraps talks to buy into RG Stone; other PE firms in fray
Private equity firm Kedaara Capital has called off negotiations to acquire India Equity Partners’ (IEP) stake in RG Stone Urology ......
